Guidelines
Bone Marrow Transplantation (2009) 44, 471–482; doi:10.1038/bmt.2009.258
Viral disease prevention after hematopoietic cell transplantation
J Zaia1, L Baden2, M J Boeckh3, S Chakrabarti4, H Einsele5, P Ljungman6, G B McDonald7 and H Hirsch8
- 1City of Hope, Duarte, CA, USA
- 2Brigham and Women's Hospital, Boston, MA, USA
- 3Department of Medicine, University of Washington Fred Hutchinson Cancer Research Center, Seattle, WA, USA
- 4St George's Hospital, London, UK
- 5Universitatsklinik Wurzburg Medizinische Klinik und Poliklinik II, Wurzburg, Germany
- 6Department of Hematology, Karolinska University Hospital, Stockholm, Sweden
- 7Department of Gastroenterology/Hepatology, University of Washington, Seattle, WA, USA
- 8Department of Biomedicine, University Hospital, Basel, Switzerland
Correspondence: Dr J Zaia, Department of Virology COH, Beckman Research Institute of the City of Hope, 1500 Duarte Road, Duarte, CA 91010, USA. E-mail: John.Zaia@gmail.com; Dr M Tomblyn, Blood & Marrow Transplantation, H Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive FOB 3, Tampa, FL 33612, USA. E-mail: marcie.tomblyn@moffitt.org
Received 20 June 2009; Accepted 20 July 2009.
Keywords:
virus, infections, hematopoietic cell transplantation
